Located at our London Bridge site, our lab is operated by fully trained laboratory staff 24 hours a day and used for immediate sample processing needs.

The laboratories include refrigerated centrifuges for sample processing, refrigerators and -20°C and -80°C freezers for sample storage. The refrigerators and freezers are linked to an alarm system and the temperature is monitored continuously. Our laboratories also have automated Drugs of Abuse (DOA) analyser, providing fast and accurate DOA results.

The Doctors Laboratory (TDL) is the central laboratory contracted by Richmond Pharmacology for the majority of studies Richmond Pharmacology are involved in. TDL is a fully CPA accredited laboratory that carries out regulatory compliant services on behalf of Richmond Pharmacology, including biochemistry, haematology, virology and microbiology. We offer a rapid turn around of routine, urgent and emergency results.

We have strong working relationships with numerous external laboratories, and through collaboration with these, Richmond Pharmacology can provide a comprehensive range of laboratory services. These services range from basic laboratory safety analyses to more extensive and complex testing requiring specialist techniques and equipment.

Combining the skills of our lab team and local lab services to produce fast, reliable results.

Get in touch today

Latest news

PATIENT WITH RARE BLEEDING DISORDER BECOMES FIRST TO TEST NEW TREATMENT

May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations

April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event